Long-term Qipian® administration confers resistance to airway inflammation in OVA-induced asthmatic mice.

Saved in:
Bibliographic Details
Title: Long-term Qipian® administration confers resistance to airway inflammation in OVA-induced asthmatic mice.
Authors: Wang H; Department of Allergy and Clinical Immunology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China., Chen RY; School of Marine Sciences, Ningbo University, Ningbo, China., Shi JJ; School of Marine Sciences, Ningbo University, Ningbo, China., Yang GJ; School of Marine Sciences, Ningbo University, Ningbo, China., Chen J; School of Marine Sciences, Ningbo University, Ningbo, China.
Source: Frontiers in allergy [Front Allergy] 2026 Feb 26; Vol. 7, pp. 1746439. Date of Electronic Publication: 2026 Feb 26 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918227355906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-6101 (Electronic) Linking ISSN: 26736101 NLM ISO Abbreviation: Front Allergy Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2673-6101
DOI:10.3389/falgy.2026.1746439